Click Therapeutics’ migraine mobile app may now be used alongside standard drug therapies as a way to prevent episodic migraine in adults. In clinical trials, daily use of the app led to a statistically significant reduction in monthly migraine days.
The post Software-as-Treatment Startup Click Therapeutics Gets FDA Authorization for Migraine Mobile App appeared first on MedCity News.
